And with so little definitive data on the long-term health effects of takingor stoppingthis new class of drugs, weight-loss companies suggestion that the drugs can be taken temporarily is worrying, says Ragen Chastain, a researcher, board-certified patient advocate, and author of a newsletter that explores weight science
It is still moving through the Phase 3 TRIUMPH program, and the earliest realistic approval window is 2027
Specific Concerns Related to Cholesterol Management While semaglutide can help lower cholesterol, there are specific concerns that patients need to be aware of: Hypoglycemia: Though semaglutide itself does not cause low blood sugar, the risk increases if it is taken with other diabetes medications, such as insulin or sulfonylureas
Sometimes what looks like a side effect from the peptide itself is actually a dosing error from incorrect reconstitution math
Ugwu SO, Blanchard J, Nguyen LD, Hadley ME, Dorr RT (1994)